IP Library Granted Patent US 6,949,367
Granted Patent B1
US 6,949,367 · App. 09/724,959 · Granted Sep 27, 2005

Modified oligonucleotides for mismatch discrimination

Assignee: Epoch Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,949,367
App. No.
09/724,959
Granted
Sep 27, 2005
Kind
B1
Abstract

Modified oligonucleotides are provided containing bases selected from unsubstituted and 3-substituted pyrazolo[3,4-d]pyrimidines and 5-substituted pyrimidines, and optionally have attached minor groove binders and reporter groups.

Claims (12)

1. A method for primer extension, the method comprising incubating a polynucleotide containing a target sequence with one or more oligonucleotide primers complementary to the target sequence, in the presence of a polymerizing enzyme and nucleotide substrates under conditions favorable for polymerization; wherein at least one of the oligonucleotide primers contains a modified base selected from the group consisting of an unsubstituted pyrazolo[3,4-d]pyrimidine, a 3-substituted pyrazolo[3,4-d]pyrimidine and a 5-substituted pyrimidine base, in place of a purine or pyrimidine base.

2. A method in accordance with claim 1 , wherein one of said oligonucleotide primers is extended with a single base.

3. A method in accordance with claim 1 , wherein said at least one of said oligonucleotide primers further comprises an attached minor groove binder.

4. A method in accordance with claim 1 , wherein said incubating is part of an amplification reaction.

5. A method in accordance with claim 4 , wherein said amplification reaction is a polymerase chain reaction.

6. A method in accordance with claim 1 , wherein said modified oligonucleotide further comprises a covalently attached minor groove binder.

7. A method for determining the nucleotide sequence of a polynucleotide, the method comprising:

(a) incubating the polynucleotide with a modified oligonucleotide array under hybridization conditions; and

(b) determining to which of the modified oligonucleotides in the array the polynucleotide hybridizes;

wherein a plurality of the modified oligonucleotides comprise at least one 3-substituted pyrazolo[3,4]pyrimidine in place of a purine base.

8. A method in accordance with claim 7 , wherein said array comprises from 10 to 100,000 different modified oligonucleotides.

9. A method in accordance with claim 7 , wherein said array comprises from 10 to 1000 different modified oligonucleotides.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: ELITECHGROUP B.V.
To: ELITECHGROUP, INC.
Reel/Frame 048078/0553 →
CHANGE OF NAME Recorded Mar 10, 2017
From: ELITECH HOLDING BV
To: ELITECHGROUP B.V.
Reel/Frame 041974/0867 →
SECURITY AGREEMENT Recorded Jun 20, 2008
From: EPOCH BIOSCIENCES, INC.
To: DRUG ROYALTY LP1
Reel/Frame 021127/0646 →
SECURITY AGREEMENT Recorded Mar 28, 2008
From: EPOCH BIOSCIENCES, INC.
To: DRUG ROYALTY LP2
Reel/Frame 020710/0969 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2006
From: EPOCH BIOSCIENCES, INC.
To: DRUG ROYALTY TRUST 9
Reel/Frame 018362/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2001
From: DEMPCY, ROBERT O.; GALL, ALEXANDER A.; LOKHOV, SERGEY G.; AFONINA, IRINA A.; SINGER, MICHAEL J.; KUTYAVIN, IGOR V.; VERMEULEN, NICOLAAS M.J.
To: EPOCH BIOSCIENCES, INC.
Reel/Frame 011984/0913 →
Continuity (5)
Continuation In Part 0964095300 · Aug 16, 2000
Continuation In Part 0943138500 · Nov 1, 1999
Continuation 0905483200 · Apr 3, 1998
Continuation 0905483000 · Apr 3, 1998
Provisional Application 6018604600 · Mar 1, 2000